BioSpace News Archive

Business

Vireo Health to Report Third Quarter 2019 Results on November 27, 2019

Will report financial results for its third quarter ended September 30, 2019 on Wednesday, November 27, 2019 before the market opens.

November 18, 2019
·
1 min read
Business

Cutera Appoints Fuad Ahmad as Interim CFO

He will assume oversight of the Company’s finance function and financial reporting while the Company conducts its national search for a permanent CFO.

November 18, 2019
·
4 min read
Drug Development

Sensei Biotherapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of SNS-301 in Patients with ASPH-Positive Head and Neck Cancer

Sensei Biotherapeutics, Inc. announced the dosing of the first patient in its Phase 1/2 clinical trial evaluating SNS-301 in patients with ASPH‑positive head and neck cancer who have previously received immune checkpoint inhibitors.

November 18, 2019
·
3 min read
Drug Development

Axial Biotherapeutics Announces Completion of Enrollment in Phase 1b/2a Clinical Trial Evaluating AB-2004 in Patients with Autism Spectrum Disorder

Axial Biotherapeutics announced the completion of enrollment in its Phase 1b/2a clinical trial evaluating AB-2004.

November 18, 2019
·
2 min read
Business

Theranica Announces U.S. Recycling Partnership in Commitment to Sustainable Medical Device Production

Partnership Advances Circular Economy by Making Nerivio™, a Prescribed Wearable for Acute Treatment of Migraine, Recyclable

November 18, 2019
·
3 min read
FDA

Breakthrough CooperVision MiSight® 1 Day Contact Lens for Childhood Myopia Coming to the United States in 2020

FDA Approval Offers New Prospects for Parents, Children and Medical Professionals; Will Become the First and Only Product of its Kind Available in the U.S.

November 18, 2019
·
8 min read
Propanc Biopharma Advances POP1 Drug Discovery Program

Propanc Developing Backup Synthetic Compound to Lead Product Candidate, PRP

November 18, 2019
·
5 min read
Biotech Bay

Amygdala Neurosciences Announces $5.6M Financing and Dr. Mack Mitchell’s Expanded Role as CMO

Funds will support current and planned Phase 2 clinical studies to assess ANS-6637 as a treatment for opioid, alcohol, and smoking/nicotine use disorders

November 18, 2019
·
2 min read
Quotient Limited to Participate in the Jefferies 2019 London Healthcare Conference

The Company is scheduled to present on Thursday, November 21, 2019 at 9:20 a.m. GMT

November 18, 2019
·
1 min read
Business

ZEISS and Oak Ridge National Laboratory Partner for Advancement of Powder Bed Additive Manufacturing

Fast recipe development combined with improved mass production yield and methodology for quality certification of AM parts, existing and new materials and processes, will be defined and demonstrated.

November 18, 2019
·
5 min read